SCHEMBL28459868

SCHEMBL28459868

CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.53
▸ EPHX2 P34913 1/20 0.53
▸ SLC6A5 Q9Y345 1/20 0.52
▸ ITGB2 P05107 3/20 0.47
▸ ICAM1 P05362 3/20 0.47
▸ ITGAL P20701 3/20 0.47
▸ QPCT Q16769 1/20 0.47
▸ QPCTL Q9NXS2 1/20 0.47
▸ REN P00797 4/20 0.45
▸ F2 P00734 2/20 0.43
▸ PRSS1 P07477 2/20 0.43
▸ PRSS2 P07478 2/20 0.43
▸ PRSS3 P35030 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ ACE2 Q9BYF1 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29615190 0.92 EPHX2 (0.60) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL3057446 0.92 EPHX2 (0.60) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL27675779 0.92 EPHX2 (0.60) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL29379300 0.85 SLC15A2 (0.66) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL18381375 0.85 EPHX2 (0.67) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL19051550 0.82 SLC15A2 (0.61) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL23787348 0.81 QPCT (0.53) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL23787478 0.81 QPCT (0.53) SLC15A2EPHX2SLC6A5ITGB2ICAM1
SCHEMBL2276192 0.80 QPCT (0.56) EPHX2SLC6A5QPCTQPCTLCYP3A4
SCHEMBL28382210 0.80 SLC15A2 (0.71) SLC15A2EPHX2SLC6A5ITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096781-A1 METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS VIBRANT HOLDINGS, LLC (US) 2025-05-08 — — WO claimed
WO-2024101587-A1 FUNCTIONAL COSMETIC COMPOSITION 문주이 2024-05-16 — — WO claimed
CN-117940113-A Injectable composition comprising hyaluronic acid and amino acid 专业皮肤护理有限公司 2024-04-26 — — CN claimed
WO-2023073718-A1 COSMETIC COMPOSITIONS FOR USE IN SKIN CARE GIGI COSMETIC LABORATORIES LTD (IL) 2023-05-04 — — WO claimed
WO-2026099172-A1 SPHINGOLIPID BASED HAIR TREATMENT SEDERMA (FR) 2026-05-15 — — WO disclosed
EP-4489718-B1 METHOD FOR ENCAPSULATING A HYDROPHOBIC COMPOUND, SUSPENSION OF STRUCTURED LIPID PARTICLES ACCORDING TO THIS METHOD, AND USES OF SAID SUSPENSION SEDERMA SA (FR) 2026-03-11 — — EP disclosed
EP-4340807-B1 HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS LUBRIZOL ADVANCED MAT INC (US) 2026-01-28 — — EP disclosed
EP-4661971-A1 COSMETIC COMPOSITION COMPRISING HYDROPHOBIC AND HYDROPHILIC TREATED PIGMENTS Chanel Parfums Beauté (FR) 2025-12-17 — — EP disclosed
CN-121059496-A Mesenchymal stem cell exosome composition and preparation method and application thereof 广州外泌体生物科技有限公司 2025-12-05 — — CN disclosed
EP-4076367-B1 COSMETIC OR DERMATOLOGICAL COMPOSITION ACTING IN PARTICULAR ON THE EFFECTS OF BLUE LIGHT ON SKIN AND ITS APPENDAGES, AND ASSOCIATED USES SEDERMA SA (FR) 2025-11-19 — — EP disclosed
EP-3518888-B1 ALKYL-PHTALIDES FOR USE IN THE COSMETIC TREATMENT OF NAILS SEDERMA SA (FR) 2025-11-19 — — EP disclosed
EP-4637797-A1 METHOD FOR OBTAINING AN EXTRACT OF PLANT ORIGIN, A COMPOSITION CONTAINING IT AND ITS COSMETIC USE SEDERMA (FR) 2025-10-29 — — EP disclosed
WO-2022106444-A1 TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE SEDERMA (FR) 2022-05-27 — — WO disclosed
WO-2022106366-A1 COSMETIC TETRAPEPTIDE, COMPOSITION AND USE SEDERMA (FR) 2022-05-27 — — WO disclosed
WO-2022106365-A1 TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE SEDERMA (FR) 2022-05-27 — — WO disclosed
US-11324687-B2 Pro-pigmenting peptides SEDERMA 2022-05-10 — — US disclosed
EP-3212688-B1 THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES LUBRIZOL ADVANCED MAT INC (US) 2022-04-13 — — EP disclosed
US-20220062139-A1 TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS SEDERMA (FR) 2022-03-03 — — US disclosed
WO-2022029579-A1 EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION LUBRIZOL ADVANCED MATERIALS, INC. (US) 2022-02-10 — — WO disclosed
CN-111679028-A High performance liquid chromatography tandem mass spectrometry detection method for four peptides in cosmetics 上海市食品药品检验所 2020-09-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220062139-A1 TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS SAP18, CYP51A1, NAA10 SLC15A2 4253/4885EPHX2 3730/4885SLC6A5 4731/4885
US-11324687-B2 Pro-pigmenting peptides MC1R, NPY1R, NR2E3 SLC15A2 800/4885EPHX2 3633/4885SLC6A5 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback